These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23313506)

  • 1. Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells.
    Wang J; Yang Q; Haffty BG; Li X; Moran MS
    Biochem Biophys Res Commun; 2013 Feb; 431(2):146-51. PubMed ID: 23313506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells].
    Feng H; Guo B; Kong X; Wu B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):940-4. PubMed ID: 27363277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair.
    Alonso-González C; González A; Martínez-Campa C; Gómez-Arozamena J; Cos S
    J Pineal Res; 2015 Mar; 58(2):189-97. PubMed ID: 25623566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-dependent regulation of Eg5 in breast cancer cells.
    Planas-Silva MD; Filatova IS
    Anticancer Drugs; 2007 Aug; 18(7):773-9. PubMed ID: 17581299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro.
    Jansen GH; Franke HR; Wolbers F; Brinkhuis M; Vermes I
    Climacteric; 2008 Aug; 11(4):315-21. PubMed ID: 18645697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization effects of berberine on human breast cancer cells.
    Wang J; Liu Q; Yang Q
    Int J Mol Med; 2012 Nov; 30(5):1166-72. PubMed ID: 22895634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letrozole sensitizes breast cancer cells to ionizing radiation.
    Azria D; Larbouret C; Cunat S; Ozsahin M; Gourgou S; Martineau P; Evans DB; Romieu G; Pujol P; Pèlegrin A
    Breast Cancer Res; 2005; 7(1):R156-63. PubMed ID: 15642164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.
    Ikeda H; Taira N; Hara F; Fujita T; Yamamoto H; Soh J; Toyooka S; Nogami T; Shien T; Doihara H; Miyoshi S
    Breast Cancer Res; 2010; 12(3):R43. PubMed ID: 20579400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
    Tan H; Zhong Y; Pan Z
    BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.
    JavanMoghadam S; Weihua Z; Hunt KK; Keyomarsi K
    Cell Cycle; 2016 Jun; 15(12):1579-90. PubMed ID: 27049344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and application of 131I-fulvestrant as a targeted radiation drug for endocrine therapy in human breast cancer.
    Yin G; Zeng B; Peng Z; Liu Y; Sun L; Liu C
    Oncol Rep; 2018 Mar; 39(3):1215-1226. PubMed ID: 29328488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.
    Ribas R; Pancholi S; Guest SK; Marangoni E; Gao Q; Thuleau A; Simigdala N; Polanska UM; Campbell H; Rani A; Liccardi G; Johnston S; Davies BR; Dowsett M; Martin LA
    Mol Cancer Ther; 2015 Sep; 14(9):2035-48. PubMed ID: 26116361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells.
    Liu H; Cheng D; Weichel AK; Osipo C; Wing LK; Chen B; Louis TE; Jordan VC
    Int J Oncol; 2006 Nov; 29(5):1237-46. PubMed ID: 17016657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader.
    Heidari P; Deng F; Esfahani SA; Leece AK; Shoup TM; Vasdev N; Mahmood U
    Clin Cancer Res; 2015 Mar; 21(6):1340-7. PubMed ID: 25609068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
    Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
    J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD; Waltz PK; Kilker RL
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.
    Zimmermann M; Arachchige-Don AP; Donaldson MS; Patriarchi T; Horne MC
    Cell Cycle; 2016 Dec; 15(23):3278-3295. PubMed ID: 27753529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.
    Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW
    Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.